Somatostatin (14 and 28) and cortistatin inhibit TNF-α release in sub-lethal endotoxemia and sepsis models
Landa et al (1995) Res Exp Med (Berl) 195:317-25 Sener et al (2005) Peptides 26:493-9 Gonzalez-Rey et al (2006). J Exp Med 203:563-71
Octreotide and cortistatin showed efficacy in rodent models of Inflammatory Bowel Disease
Eliakim et al (1993) Gut 34:264-9 Lamrani et al (1999) Alim Pharmacol &Ther 13:583-94 Gonzalez-Rey et al (2006) PNAS USA 103:4228-33
Octreotide and cortistatin showed efficacy in rodent models of RA
Kurnatowska et al (2000) Neuro Endocrinol Lett 21:121-6 Gonzalez-Rey et al (2007) Ann Rheum Dis 66:582 Imhof et al (2011) Arthritis Rheum
Vapreotide showed efficacy in Crohn’s disease patients
Cortot et al (1994) Gut 35:F285
Somatostatin and octreotide showed efficacy in psoriasis and psoriatic arthritis patients
Weber et al (1982) Arch Dermatol Res 272:31-6 Guilhou et al (1982) Arch Dermatol Res 274:249-57 Matucci-Cerinic M et al (1988) Int J Dermatol 27:56-8 Venier et al (1988) Arch Dermatol Res 280:S51-4 Camisa et al (1990) Cleveland Clin J Med 57:71-6
SITE MAP 
CONTACT US
SITE MAP CONTACT US